{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T20:20:42Z","timestamp":1770495642309,"version":"3.49.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T00:00:00Z","timestamp":1732233600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T00:00:00Z","timestamp":1732233600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"The Science and Technology Program of Yunnan Provincial Department of Science and Technology","award":["202101AY070001-231"],"award-info":[{"award-number":["202101AY070001-231"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-024-04284-2","type":"journal-article","created":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T15:00:33Z","timestamp":1732287633000},"page":"691-700","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Potential next generation markers of testicular germ cell tumors: miRNA-371a-3p"],"prefix":"10.1007","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-3305-3864","authenticated-orcid":false,"given":"Shan","family":"Zujuan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deng","family":"Xin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhang","family":"Guifu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,22]]},"reference":[{"issue":"5","key":"4284_CR1","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.eururo.2022.06.016","volume":"82","author":"H Moch","year":"2022","unstructured":"Moch H, Amin MB, Berney DM et al (2022) The 2022 World Health Organization classification of tumours of the urinary system and male genital organs-part A: renal, penile, and testicular tumours. Eur Urol 82(5):458\u2013468. https:\/\/doi.org\/10.1016\/j.eururo.2022.06.016","journal-title":"Eur Urol"},{"issue":"5","key":"4284_CR2","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.eururo.2019.07.002","volume":"76","author":"JK Gurney","year":"2019","unstructured":"Gurney JK, Florio AA, Znaor A et al (2019) International trends in the incidence of testicular cancer: Lessons from 35 years and 41 countries [J]. Eur Urol 76(5):615\u2013623. https:\/\/doi.org\/10.1016\/j.eururo.2019.07.002","journal-title":"Eur Urol"},{"issue":"37","key":"4284_CR3","doi-asserted-by":"publisher","first-page":"e12390","DOI":"10.1097\/MD.0000000000012390","volume":"97","author":"JS Park","year":"2018","unstructured":"Park JS, Kim J, Elghiaty A et al (2018) Recent global trends in testicular cancer incidence and mortality [J]. Medicine (Baltimore) 97(37):e12390. https:\/\/doi.org\/10.1097\/MD.0000000000012390","journal-title":"Medicine (Baltimore)"},{"issue":"12","key":"4284_CR4","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/nrurol.2016.170","volume":"13","author":"MJ Murray","year":"2016","unstructured":"Murray MJ, Huddart RA, Coleman N (2016) The present and future of serum diagnostic tests for testicular germ cell tumours. Nat Rev Urol 13(12):715\u2013725. https:\/\/doi.org\/10.1038\/nrurol.2016.170. (Epub 2016 Oct 18)","journal-title":"Nat Rev Urol"},{"issue":"2","key":"4284_CR5","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.eururo.2016.07.029","volume":"71","author":"KP Dieckmann","year":"2017","unstructured":"Dieckmann KP, Radtke A, Spiekermann M et al (2017) Serum levels of microrna mir-371a-3p: a sensitive and specific new biomarker for germ cell tumours [J]. Eur Urol 71(2):213\u2013220. https:\/\/doi.org\/10.1016\/j.eururo.2016.07.029","journal-title":"Eur Urol"},{"issue":"16","key":"4284_CR6","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1200\/JCO.18.01480","volume":"37","author":"KP Dieckmann","year":"2019","unstructured":"Dieckmann KP, Radtke A, Geczi L et al (2019) Serum levels of microrna-371a-3p (m371 test) as a new biomarker of testicular germ cell tumors: results of a prospective multicentric study [J]. J Clin Oncol 37(16):1412\u20131423. https:\/\/doi.org\/10.1200\/JCO.18.01480","journal-title":"J Clin Oncol"},{"issue":"1748","key":"4284_CR7","doi-asserted-by":"publisher","first-page":"20170338","DOI":"10.1098\/rstb.2017.0338","volume":"373","author":"B Vilela-Salgueiro","year":"2018","unstructured":"Vilela-Salgueiro B, Barros-Silva D, Lobo J et al (2018) Germ cell tumour subtypes display differential expression of microrna371a-3p [J]. Philos Trans R Soc Lond B Biol Sci 373(1748):20170338. https:\/\/doi.org\/10.1098\/rstb.2017.0338","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"4","key":"4284_CR8","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.jaci.2017.08.034","volume":"141","author":"TX Lu","year":"2018","unstructured":"Lu TX, Rothenberg ME (2018) Microrna [J]. J Allergy Clin Immunol 141(4):1202\u20131207. https:\/\/doi.org\/10.1016\/j.jaci.2017.08.034","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"4284_CR9","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/0092-8674(93)90529-y","volume":"75","author":"RC Lee","year":"1993","unstructured":"Lee RC, Feinbaum RL, Ambros V (1993) The c Elegans heterochronic gene lin-4 encodes small rnas with antisense complementarity to lin-14 [J]. Cell 75(5):843\u2013854. https:\/\/doi.org\/10.1016\/0092-8674(93)90529-y","journal-title":"Cell"},{"issue":"3","key":"4284_CR10","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1261\/rna.2183803","volume":"9","author":"V Ambros","year":"2003","unstructured":"Ambros V, Bartel B, Bartel DP et al (2003) A uniform system for microrna annotation [J]. RNA 9(3):277\u2013279. https:\/\/doi.org\/10.1261\/rna.2183803","journal-title":"RNA"},{"key":"4284_CR11","doi-asserted-by":"publisher","first-page":"933","DOI":"10.3389\/fgene.2019.00933","volume":"10","author":"O Plotnikova","year":"2019","unstructured":"Plotnikova O, Baranova A, Skoblov M (2019) Comprehensive analysis of human microrna-mrna interactome [J]. Front Genet 10:933. https:\/\/doi.org\/10.3389\/fgene.2019.00933","journal-title":"Front Genet"},{"key":"4284_CR12","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/978-0-387-69116-9_2","volume":"604","author":"PM Voorhoeve","year":"2007","unstructured":"Voorhoeve PM, le Sage C, Schrier M et al (2007) A genetic screen implicates mirna-372 and mirna-373 as oncogenes in testicular germ cell tumors [J]. Adv Exp Med Biol 604:17\u201346. https:\/\/doi.org\/10.1007\/978-0-387-69116-9_2","journal-title":"Adv Exp Med Biol"},{"issue":"3","key":"4284_CR13","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1002\/path.2230","volume":"213","author":"AJ Gillis","year":"2007","unstructured":"Gillis AJ, Stoop HJ, Hersmus R et al (2007) High-throughput micrornaome analysis in human germ cell tumours [J]. J Pathol 213(3):319\u2013328. https:\/\/doi.org\/10.1002\/path.2230","journal-title":"J Pathol"},{"issue":"7","key":"4284_CR14","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1158\/0008-5472.CAN-09-3301","volume":"70","author":"RD Palmer","year":"2010","unstructured":"Palmer RD, Murray MJ, Saini HK et al (2010) Malignant germ cell tumors display common microrna profiles resulting in global changes in expression of messenger rna targets [J]. Cancer Res 70(7):2911\u20132923. https:\/\/doi.org\/10.1158\/0008-5472.CAN-09-3301","journal-title":"Cancer Res"},{"issue":"1","key":"4284_CR15","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1309\/AJCPOE11KEYZCJHT","volume":"135","author":"MJ Murray","year":"2011","unstructured":"Murray MJ, Halsall DJ, Hook CE et al (2011) Identification of micrornas from the mir-371~373 and mir-302 clusters as potential serum biomarkers of malignant germ cell tumors [J]. Am J Clin Pathol 135(1):119\u2013125. https:\/\/doi.org\/10.1309\/AJCPOE11KEYZCJHT","journal-title":"Am J Clin Pathol"},{"issue":"5","key":"4284_CR16","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/j.eururo.2012.02.037","volume":"61","author":"G Belge","year":"2012","unstructured":"Belge G, Dieckmann KP, Spiekermann M et al (2012) Serum levels of micrornas mir-371-3: A novel class of serum biomarkers for testicular germ cell tumors? [J]. Eur Urol 61(5):1068\u20131069. https:\/\/doi.org\/10.1016\/j.eururo.2012.02.037","journal-title":"Eur Urol"},{"issue":"1","key":"4284_CR17","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.juro.2014.07.010","volume":"193","author":"I Syring","year":"2015","unstructured":"Syring I, Bartels J, Holdenrieder S et al (2015) Circulating serum mirna (mir-367-3p, mir-371a-3p, mir-372-3p and mir-373-3p) as biomarkers in patients with testicular germ cell cancer [J]. J Urol 193(1):331\u2013337. https:\/\/doi.org\/10.1016\/j.juro.2014.07.010","journal-title":"J Urol"},{"issue":"35","key":"4284_CR18","doi-asserted-by":"publisher","first-page":"58037","DOI":"10.18632\/oncotarget.10867","volume":"8","author":"T Van Agthoven","year":"2017","unstructured":"Van Agthoven T, Looijenga LHJ (2017) Accurate primary germ cell cancer diagnosis using serum based microrna detection (amptsmir test) [J]. Oncotarget 8(35):58037\u201358049. https:\/\/doi.org\/10.18632\/oncotarget.10867","journal-title":"Oncotarget"},{"issue":"10","key":"4284_CR19","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1038\/bjc.2012.469","volume":"107","author":"KP Dieckmann","year":"2012","unstructured":"Dieckmann KP, Spiekermann M, Balks T et al (2012) Micrornas mir-371-3 in serum as diagnostic tools in the management of testicular germ cell tumours [J]. Br J Cancer 107(10):1754\u20131760. https:\/\/doi.org\/10.1038\/bjc.2012.469","journal-title":"Br J Cancer"},{"issue":"1","key":"4284_CR20","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/j.2047-2927.2014.00269.x","volume":"3","author":"M Spiekermann","year":"2015","unstructured":"Spiekermann M, Belge G, Winter N et al (2015) Microrna mir-371a-3p in serum of patients with germ cell tumours: evaluations for establishing a serum biomarker [J]. Andrology 3(1):78\u201384. https:\/\/doi.org\/10.1111\/j.2047-2927.2014.00269.x","journal-title":"Andrology"},{"issue":"1","key":"4284_CR21","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1159\/000444303","volume":"97","author":"KP Dieckmann","year":"2016","unstructured":"Dieckmann KP, Spiekermann M, Balks T et al (2016) Microrna mir-371a-3p - a novel serum biomarker of testicular germ cell tumors: Evidence for specificity from measurements in testicular vein blood and in neoplastic hydrocele fluid [J]. Urol Int 97(1):76\u201383. https:\/\/doi.org\/10.1159\/000444303","journal-title":"Urol Int"},{"issue":"10","key":"4284_CR22","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.3390\/cells8101221","volume":"8","author":"X Rosas Plaza","year":"2019","unstructured":"Rosas Plaza X, van Agthoven T, Meijer C et al (2019) Mir-371a-3p, mir-373-3p and mir-367-3p as serum biomarkers in metastatic testicular germ cell cancers before, during and after chemotherapy [J]. Cells 8(10):1221. https:\/\/doi.org\/10.3390\/cells8101221","journal-title":"Cells"},{"issue":"4","key":"4284_CR23","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1159\/000488771","volume":"100","author":"A Radtke","year":"2018","unstructured":"Radtke A, Hennig F, Ikogho R et al (2018) The novel biomarker of germ cell tumours, micro-rna-371a-3p, has a very rapid decay in patients with clinical stage 1 [J]. Urol Int 100(4):470\u2013475. https:\/\/doi.org\/10.1159\/000488771","journal-title":"Urol Int"},{"issue":"1","key":"4284_CR24","doi-asserted-by":"publisher","first-page":"15582","DOI":"10.1038\/s41598-021-94812-2","volume":"11","author":"MP Myklebust","year":"2021","unstructured":"Myklebust MP, Thor A, Rosenlund B et al (2021) Serum mir371 in testicular germ cell cancer before and after orchiectomy, assessed by digital-droplet pcr in a prospective study [J]. Sci Rep 11(1):15582. https:\/\/doi.org\/10.1038\/s41598-021-94812-2","journal-title":"Sci Rep"},{"issue":"3 Suppl","key":"4284_CR25","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1002\/1097-0142(19870801)60:3+<464::aid-cncr2820601506>3.0.co;2-c","volume":"60","author":"PH Lange","year":"1987","unstructured":"Lange PH, Winfield HN (1987) Biological markers in urologic cancer. Cancer 60(3 Suppl):464\u2013472. https:\/\/doi.org\/10.1002\/1097-0142(19870801)60:3+%3c464::aid-cncr2820601506%3e3.0.co;2-c","journal-title":"Cancer"},{"issue":"15","key":"4284_CR26","doi-asserted-by":"publisher","first-page":"3944","DOI":"10.3390\/cancers15153944","volume":"15","author":"T Nestler","year":"2023","unstructured":"Nestler T, Schoch J, Belge G et al (2023) Microrna-371a-3p-the novel serum biomarker in testicular germ cell tumors [J]. Cancers (Basel) 15(15):3944. https:\/\/doi.org\/10.3390\/cancers15153944","journal-title":"Cancers (Basel)"},{"issue":"2","key":"4284_CR27","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/bjc.2015.429","volume":"114","author":"MJ Murray","year":"2016","unstructured":"Murray MJ, Bell E, Raby KL et al (2016) A pipeline to quantify serum and cerebrospinal fluid microRNAs for diagnosis and detection of relapse in paediatric malignant germ-cell tumours. Br J Cancer 114(2):151\u2013162. https:\/\/doi.org\/10.1038\/bjc.2015.429","journal-title":"Br J Cancer"},{"issue":"1","key":"4284_CR28","doi-asserted-by":"publisher","first-page":"vdaa048","DOI":"10.1093\/noajnl\/vdaa048","volume":"2","author":"MJ Murray","year":"2020","unstructured":"Murray MJ, Ajithkumar T, Harris F et al (2020) Clinical utility of circulating miR-371a-3p for the management of patients with intracranial malignant germ cell tumors. Neurooncol Adv. 2(1):vdaa048. https:\/\/doi.org\/10.1093\/noajnl\/vdaa048","journal-title":"Neurooncol Adv."},{"issue":"4","key":"4284_CR29","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1093\/neuonc\/noab242","volume":"24","author":"H Nakamura","year":"2022","unstructured":"Nakamura H, Takami H, Yanagisawa T et al (2022) The Japan Society for Neuro-Oncology guideline on the diagnosis and treatment of central nervous system germ cell tumors. Neuro Oncol 24(4):503\u2013515. https:\/\/doi.org\/10.1093\/neuonc\/noab242","journal-title":"Neuro Oncol"},{"issue":"12","key":"4284_CR30","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.3390\/cells8121637","volume":"8","author":"J Lobo","year":"2019","unstructured":"Lobo J, Gillis AJM, van den Berg A et al (2019) Identification and validation model for informative liquid biopsy-based microrna biomarkers: Insights from germ cell tumor in vitro, in vivo and patient-derived data [J]. Cells 8(12):1637. https:\/\/doi.org\/10.3390\/cells8121637","journal-title":"Cells"},{"issue":"17","key":"4284_CR31","doi-asserted-by":"publisher","first-page":"4260","DOI":"10.3390\/cancers13174260","volume":"13","author":"DM Timmerman","year":"2021","unstructured":"Timmerman DM, Gillis AJM, Mego M et al (2021) Comparative analyses of liquid-biopsy microrna371a-3p isolation protocols for serum and plasma [J]. Cancers (Basel) 13(17):4260. https:\/\/doi.org\/10.3390\/cancers13174260","journal-title":"Cancers (Basel)"},{"issue":"3","key":"4284_CR32","doi-asserted-by":"publisher","first-page":"759","DOI":"10.3390\/cancers12030759","volume":"12","author":"N M\u00f8rup","year":"2020","unstructured":"M\u00f8rup N, Rajpert-De Meyts E, Juul A et al (2020) Evaluation of circulating mirna biomarkers of testicular germ cell tumors during therapy and follow-up-a copenhagen experience [J]. Cancers (Basel) 12(3):759. https:\/\/doi.org\/10.3390\/cancers12030759","journal-title":"Cancers (Basel)"},{"key":"4284_CR33","doi-asserted-by":"publisher","first-page":"1056823","DOI":"10.3389\/fonc.2022.1056823","volume":"12","author":"AJ Christiansen","year":"2022","unstructured":"Christiansen AJ, Lobo J, Fankhauser CD et al (2022) Impact of differing methodologies for serum mirna-371a-3p assessment in stage i testicular germ cell cancer recurrence [J]. Front Oncol 12:1056823. https:\/\/doi.org\/10.3389\/fonc.2022.1056823","journal-title":"Front Oncol"},{"key":"4284_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.876732","volume":"12","author":"JP Sequeira","year":"2022","unstructured":"Sequeira JP, Lobo J, Const\u00e2ncio V et al (2022) Digimir test: establishing a novel pipeline for mir-371a quantification using droplet digital pcr in liquid biopsies from testicular germ cell tumor patients [J]. Front Oncol 12:876732. https:\/\/doi.org\/10.3389\/fonc.2022.876732","journal-title":"Front Oncol"},{"issue":"8","key":"4284_CR35","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.jmoldx.2022.04.007","volume":"24","author":"F Ye","year":"2022","unstructured":"Ye F, Feldman DR, Valentino A et al (2022) Analytical validation and performance characteristics of molecular serum biomarkers, mir-371a-3p and mir-372-3p, for male germ cell tumors, in a clinical laboratory setting [J]. J Mol Diagn 24(8):867\u2013877. https:\/\/doi.org\/10.1016\/j.jmoldx.2022.04.007","journal-title":"J Mol Diagn"},{"key":"4284_CR36","doi-asserted-by":"publisher","first-page":"463","DOI":"10.3389\/fgene.2019.00463","volume":"10","author":"MP Myklebust","year":"2019","unstructured":"Myklebust MP, Rosenlund B, Gjengst\u00f8 P et al (2019) Quantitative pcr measurement of mir-371a-3p and mir-372-p is influenced by hemolysis [J]. Front Genet 10:463. https:\/\/doi.org\/10.3389\/fgene.2019.00463","journal-title":"Front Genet"},{"issue":"10","key":"4284_CR37","doi-asserted-by":"publisher","first-page":"7079","DOI":"10.1007\/s00432-023-04664-8","volume":"149","author":"KP Dieckmann","year":"2023","unstructured":"Dieckmann KP, Dumlupinar C, Grobelny F et al (2023) Testicular neoplasms: The interrelationships of serum levels of microrna-371a-3p (m371) and classical tumor markers with histology, clinical staging, and age-a statistical analysis [J]. J Cancer Res Clin Oncol 149(10):7079\u20137090. https:\/\/doi.org\/10.1007\/s00432-023-04664-8","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"4284_CR38","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1097\/JU.0000000000001337","volume":"205","author":"RR Badia","year":"2021","unstructured":"Badia RR, Abe D, Wong D et al (2021) Real-world application of pre-orchiectomy mir-371a-3p test in testicular germ cell tumor management [J]. J Urol 205(1):137\u2013144. https:\/\/doi.org\/10.1097\/JU.0000000000001337","journal-title":"J Urol"},{"issue":"6","key":"4284_CR39","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1093\/annonc\/mdi175","volume":"16","author":"CE Hoei-Hansen","year":"2005","unstructured":"Hoei-Hansen CE, Rajpert-De Meyts E, Daugaard G, Skakkebaek NE (2005) Carcinoma in situ testis, the progenitor of testicular germ cell tumours: a clinical review. Ann Oncol 16(6):863\u2013868. https:\/\/doi.org\/10.1093\/annonc\/mdi175","journal-title":"Ann Oncol"},{"issue":"4","key":"4284_CR40","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.annonc.2022.01.002","volume":"33","author":"J Oldenburg","year":"2022","unstructured":"Oldenburg J, Berney DM, Bokemeyer C et al (2022) Testicular seminoma and non-seminoma: ESMO-EURACAN clinical practice guideline for diagnosis, treatment and follow-up. Ann Oncol 33(4):362\u2013375. https:\/\/doi.org\/10.1016\/j.annonc.2022.01.002","journal-title":"Ann Oncol"},{"issue":"3","key":"4284_CR41","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1530\/ERC-11-0271","volume":"19","author":"GW Novotny","year":"2012","unstructured":"Novotny GW, Belling KC, Bramsen JB et al (2012) Microrna expression profiling of carcinoma in situ cells of the testis [J]. Endocr Relat Cancer 19(3):365\u2013379. https:\/\/doi.org\/10.1530\/ERC-11-0271","journal-title":"Endocr Relat Cancer"},{"issue":"11","key":"4284_CR42","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1007\/s00432-017-2490-7","volume":"143","author":"A Radtke","year":"2017","unstructured":"Radtke A, Cremers JF, Kliesch S et al (2017) Can germ cell neoplasia in situ be diagnosed by measuring serum levels of microrna371a-3p? [J]. J Cancer Res Clin Oncol 143(11):2383\u20132392. https:\/\/doi.org\/10.1007\/s00432-017-2490-7","journal-title":"J Cancer Res Clin Oncol"},{"key":"4284_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.889624","volume":"12","author":"KP Dieckmann","year":"2022","unstructured":"Dieckmann KP, Klemke M, Grobelny F et al (2022) Serum levels of microrna-371a-3p (m371) can predict absence or presence of vital disease in residual masses after chemotherapy of metastatic seminoma [J]. Front Oncol 12:889624. https:\/\/doi.org\/10.3389\/fonc.2022.889624","journal-title":"Front Oncol"},{"issue":"21","key":"4284_CR44","doi-asserted-by":"publisher","first-page":"5447","DOI":"10.3390\/cancers14215447","volume":"14","author":"KP Dieckmann","year":"2022","unstructured":"Dieckmann KP, Isbarn H, Grobelny F et al (2022) Testicular neoplasms: primary tumour size is closely interrelated with histology, clinical staging, and tumour marker expression rates-a comprehensive statistical analysis [J]. Cancers (Basel) 14(21):5447. https:\/\/doi.org\/10.3390\/cancers14215447","journal-title":"Cancers (Basel)"},{"issue":"2","key":"4284_CR45","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s00432-020-03429-x","volume":"147","author":"G Belge","year":"2021","unstructured":"Belge G, Grobelny F, Radtke A et al (2021) Serum levels of microrna-371a-3p are not elevated in testicular tumours of non-germ cell origin [J]. J Cancer Res Clin Oncol 147(2):435\u2013443. https:\/\/doi.org\/10.1007\/s00432-020-03429-x","journal-title":"J Cancer Res Clin Oncol"},{"issue":"4","key":"4284_CR46","doi-asserted-by":"publisher","first-page":"242","DOI":"10.22037\/uj.v20i.8002","volume":"21","author":"MT K\u0131l\u0131n\u00e7","year":"2024","unstructured":"K\u0131l\u0131n\u00e7 MT, G\u00f6ger YE, \u00d6zkent MS et al (2024) Micro-RNA-371a-3p in germ cell testicular tumors on diagnosis: a prospective case-control study in turkish population. Urol J 21(4):242\u2013249. https:\/\/doi.org\/10.22037\/uj.v20i.8002","journal-title":"Urol J"},{"issue":"4","key":"4284_CR47","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.eururo.2021.06.006","volume":"80","author":"R Le\u00e3o","year":"2021","unstructured":"Le\u00e3o R, Albersen M, Looijenga LHJ et al (2021) Circulating micrornas, the next-generation serum biomarkers in testicular germ cell tumours: a systematic review [J]. Eur Urol 80(4):456\u2013466. https:\/\/doi.org\/10.1016\/j.eururo.2021.06.006","journal-title":"Eur Urol"},{"issue":"3","key":"4284_CR48","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s40291-021-00521-x","volume":"25","author":"Q Liu","year":"2021","unstructured":"Liu Q, Lian Q, Lv H et al (2021) The diagnostic accuracy of mir-371a-3p for testicular germ cell tumors: a systematic review and meta-analysis [J]. Mol Diagn Ther 25(3):273\u2013281. https:\/\/doi.org\/10.1007\/s40291-021-00521-x","journal-title":"Mol Diagn Ther"},{"issue":"6","key":"4284_CR49","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.clgc.2021.08.006","volume":"19","author":"J Piao","year":"2021","unstructured":"Piao J, Lafin JT, Scarpini CG et al (2021) A multi-institutional pooled analysis demonstrates that circulating mir-371a-3p alone is sufficient for testicular malignant germ cell tumor diagnosis [J]. Clin Genitourin Cancer 19(6):469\u2013479. https:\/\/doi.org\/10.1016\/j.clgc.2021.08.006","journal-title":"Clin Genitourin Cancer"},{"issue":"2","key":"4284_CR50","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.eururo.2019.10.005","volume":"77","author":"JT Lafin","year":"2020","unstructured":"Lafin JT, Singla N, Woldu SL et al (2020) Serum microrna-371a-3p levels predict viable germ cell tumor in chemotherapy-na\u00efve patients undergoing retroperitoneal lymph node dissection [J]. Eur Urol 77(2):290\u2013292. https:\/\/doi.org\/10.1016\/j.eururo.2019.10.005","journal-title":"Eur Urol"},{"issue":"1","key":"4284_CR51","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.juro.2018.02.068","volume":"200","author":"R Le\u00e3o","year":"2018","unstructured":"Le\u00e3o R, van Agthoven T, Figueiredo A et al (2018) Serum mirna predicts viable disease after chemotherapy in patients with testicular nonseminoma germ cell tumor [J]. J Urol 200(1):126\u2013135. https:\/\/doi.org\/10.1016\/j.juro.2018.02.068","journal-title":"J Urol"},{"key":"4284_CR52","unstructured":"European Association of Urology Guidelines on Testicular Cancer: 2024 Update (https:\/\/uroweb.org\/guidelines\/testicular-cancer\/chapter\/introduction)"},{"issue":"1","key":"4284_CR53","doi-asserted-by":"publisher","first-page":"10558","DOI":"10.1038\/s41598-023-37271-1","volume":"13","author":"JT Lafin","year":"2023","unstructured":"Lafin JT, Scarpini CG, Amini A et al (2023) Refining the serum miR-371a-3p test for viable germ cell tumor detection. Sci Rep 13(1):10558. https:\/\/doi.org\/10.1038\/s41598-023-37271-1","journal-title":"Sci Rep"},{"issue":"4","key":"4284_CR54","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1111\/andr.13317","volume":"11","author":"B Konneh","year":"2023","unstructured":"Konneh B, Lafin JT, Howard J et al (2023) Evaluation of mir-371a-3p to predict viable germ cell tumor in patients with pure seminoma receiving retroperitoneal lymph node dissection [J]. Andrology 11(4):634\u2013640. https:\/\/doi.org\/10.1111\/andr.13317","journal-title":"Andrology"},{"issue":"3","key":"4284_CR55","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.euo.2023.10.021","volume":"7","author":"F Seelemeyer","year":"2024","unstructured":"Seelemeyer F, Pfister D, Pappesch R et al (2024) Evaluation of a miRNA-371a-3p assay for predicting final histopathology in patients undergoing primary nerve-sparing retroperitoneal lymphadenectomy for stage iia\/b seminoma or nonseminoma. Eur Urol Oncol 7(3):319\u2013322. https:\/\/doi.org\/10.1016\/j.euo.2023.10.021","journal-title":"Eur Urol Oncol"},{"issue":"5","key":"4284_CR56","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1097\/JU.0000000000004164","volume":"212","author":"A Thor","year":"2024","unstructured":"Thor A, Myklebust MP, Grenabo Bergdahl A et al (2024) miR-371a-3p predicting viable tumor in patients undergoing retroperitoneal lymph node dissection for metastatic testicular cancer: the SWENOTECA-MIR study. J Urol 212(5):720\u2013730. https:\/\/doi.org\/10.1097\/JU.0000000000004164","journal-title":"J Urol"},{"issue":"11","key":"4284_CR57","doi-asserted-by":"publisher","first-page":"3392","DOI":"10.1016\/j.celrep.2018.05.039","volume":"23","author":"H Shen","year":"2018","unstructured":"Shen H, Shih J, Hollern DP et al (2018) Integrated molecular characterization of testicular germ cell tumors. Cell Rep 23(11):3392\u20133406. https:\/\/doi.org\/10.1016\/j.celrep.2018.05.039","journal-title":"Cell Rep"},{"issue":"1","key":"4284_CR58","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.eururo.2020.10.024","volume":"79","author":"L Nappi","year":"2021","unstructured":"Nappi L, Thi M, Adra N et al (2021) Integrated expression of circulating miR375 and miR371 to identify teratoma and active germ cell malignancy components in malignant germ cell tumors. Eur Urol 79(1):16\u201319. https:\/\/doi.org\/10.1016\/j.eururo.2020.10.024","journal-title":"Eur Urol"},{"issue":"1","key":"4284_CR59","doi-asserted-by":"publisher","first-page":"163","DOI":"10.21873\/invivo.11757","volume":"34","author":"G Belge","year":"2020","unstructured":"Belge G, Grobelny F, Matthies C, Radtke A, Dieckmann KP (2020) Serum level of microRNA-375-3p is not a reliable biomarker of teratoma. In Vivo 34(1):163\u2013168. https:\/\/doi.org\/10.21873\/invivo.11757","journal-title":"In Vivo"},{"key":"4284_CR60","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.euros.2021.02.003","volume":"26","author":"JT Lafin","year":"2021","unstructured":"Lafin JT, Kenigsberg AP, Meng X et al (2021) Serum small RNA sequencing and miR-375 assay do not identify the presence of pure teratoma at postchemotherapy retroperitoneal lymph node dissection. Eur Urol Open Sci 26:83\u201387. https:\/\/doi.org\/10.1016\/j.euros.2021.02.003. (Epub 2021 Mar 5)","journal-title":"Eur Urol Open Sci"},{"issue":"1","key":"4284_CR61","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/bco2.143","volume":"4","author":"JA Moore","year":"2022","unstructured":"Moore JA, Lehner MJ, Anfossi S et al (2022) Predictive capacity of a miRNA panel in identifying teratoma in post-chemotherapy consolidation surgeries. BJUI Compass 4(1):81\u201387. https:\/\/doi.org\/10.1002\/bco2.143","journal-title":"BJUI Compass"},{"issue":"8","key":"4284_CR62","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1038\/s41416-021-01643-z","volume":"126","author":"CD Fankhauser","year":"2022","unstructured":"Fankhauser CD, Christiansen AJ, Rothermundt C et al (2022) Detection of recurrences using serum mir-371a-3p during active surveillance in men with stage i testicular germ cell tumours [J]. Br J Cancer 126(8):1140\u20131144. https:\/\/doi.org\/10.1038\/s41416-021-01643-z","journal-title":"Br J Cancer"},{"issue":"2","key":"4284_CR63","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1158\/1078-0432.CCR-23-0730","volume":"30","author":"G Belge","year":"2024","unstructured":"Belge G, Dumlupinar C, Nestler T et al (2024) Detection of recurrence through microRNA-371a-3p serum levels in a follow-up of stage I testicular germ cell tumors in the DRKS-00019223 study. Clin Cancer Res 30(2):404\u2013412. https:\/\/doi.org\/10.1158\/1078-0432.CCR-23-0730","journal-title":"Clin Cancer Res"},{"issue":"2","key":"4284_CR64","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1111\/jcmm.14013","volume":"23","author":"M Mego","year":"2019","unstructured":"Mego M, van Agthoven T, Gronesova P et al (2019) Clinical utility of plasma mir-371a-3p in germ cell tumors [J]. J Cell Mol Med 23(2):1128\u20131136. https:\/\/doi.org\/10.1111\/jcmm.14013","journal-title":"J Cell Mol Med"},{"issue":"3","key":"4284_CR65","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.euo.2020.11.004","volume":"4","author":"J Lobo","year":"2021","unstructured":"Lobo J, Le\u00e3o R, Gillis AJM et al (2021) Utility of serum mir-371a-3p in predicting relapse on surveillance in patients with clinical stage i testicular germ cell cancer [J]. Eur Urol Oncol 4(3):483\u2013491. https:\/\/doi.org\/10.1016\/j.euo.2020.11.004","journal-title":"Eur Urol Oncol"},{"issue":"4","key":"4284_CR66","doi-asserted-by":"publisher","first-page":"e733","DOI":"10.1016\/j.clgc.2019.03.015","volume":"17","author":"D Charytonowicz","year":"2019","unstructured":"Charytonowicz D, Aubrey H, Bell C et al (2019) Cost analysis of noninvasive blood-based microrna testing versus ct scans for follow-up in patients with testicular germ-cell tumors [J]. Clin Genitourin Cancer 17(4):e733\u2013e744. https:\/\/doi.org\/10.1016\/j.clgc.2019.03.015","journal-title":"Clin Genitourin Cancer"},{"issue":"1","key":"4284_CR67","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/bju.15288","volume":"128","author":"A Bagrodia","year":"2021","unstructured":"Bagrodia A, Savelyeva A, Lafin JT et al (2021) Impact of circulating microrna test (mirna-371a-3p) on appropriateness of treatment and cost outcomes in patients with stage i non-seminomatous germ cell tumours [J]. BJU Int 128(1):57\u201364. https:\/\/doi.org\/10.1111\/bju.15288","journal-title":"BJU Int"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-024-04284-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-024-04284-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-024-04284-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T14:57:17Z","timestamp":1739372237000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-024-04284-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,22]]},"references-count":67,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["4284"],"URL":"https:\/\/doi.org\/10.1007\/s11255-024-04284-2","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,22]]},"assertion":[{"value":"17 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have completed the ICMJE uniform disclosure form. The authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}